Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SAFE-iPS - France's First Hospital-based Platform for the Production of Induced Pluripotent Stem Cells for the Regenerative Medicine of the Future

NCT07735559 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT07735559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07735559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SAFE-iPS - France's First Hospital-based Platform for the Production of Induced Pluripotent Stem Cells for the Regenerative Medicine of the Future
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
February 29, 2028
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

induced pluripotent stem cells (ipsc) production, regenerative medicine